Rexahn Pharmaceuticals, Inc. (RNN)’s Stock Price Update:
Rexahn Pharmaceuticals, Inc. (RNN) stock price ended its day with loss -4.55% and finalized at the price of $0.40. During its last trading session, Stock traded with the total exchanged volume of 2.26 million shares. The average volume stands around 6.82 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 0.33. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. Rexahn Pharmaceuticals, Inc. (RNN) is a part of Healthcare sector and belongs to Biotechnology industry.
ATR value of company was 0.05. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. ATR can display volatility of stocks, ETFs and indexes. The principal of ATR is very similar to other volatility indicators: A high ATR value signals a possible trend change. A low ATR value correlates with a weaker trend movement.
USA based company, Rexahn Pharmaceuticals, Inc. (RNN)’s latest closing price distance was 55.61% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -5.60% and -20.17% compared with the 20 Day Moving Average.
To review the RNN previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost -12.79%.
During last one month it showed the change of -27.75%.
During last 3 month it remained at 131.93%.
During last 12 month it moved at 42.45%.
Along with these its year to date performance is standing at 182.59%.
Relative Strength Index (RSI) was 43.32. The stock volatility for week was 8.66% while for month was 11.86%.The stock, as of last close, traded 215.75% to its 52 week low and was changed -43.52% from its 52 week high. Beta factor, which measures the riskiness of the security, was observed as -0.38. RNN’s value Change from Open was at -3.77% with a Gap of -0.81%.
EPS growth in past 5 year was 18.90%.
EPS growth in next year is estimated to reach -12.50% while EPS growth estimate for this year is set at 45.70%.
Analysts’ mean recommendation for Rexahn Pharmaceuticals, Inc. (RNN) stands at 1.70. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
Price Target Update:
A price target is the projected price level of a financial security stated by an investment analyst or advisor. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. Analysts are estimating that Rexahn Pharmaceuticals, Inc. (RNN) to hit $2.33 Price Target in next one year, this mean price is come up through the consensus of analysts. The Median price target for the stock is set at $2.00. Highest potential price target is expected at $3.00 however minimum price target advised by analysts is $2.00. Essentially, a price target is an individual analyst’s expectation on the future price of a security, usually a stock. There may be many price targets for a single security. An influential analyst on Wall Street may give a stock that is currently trading at $60 a one-year price target of $90; however, there is no concrete way to calculate a price target. Different analysts and financial institutions use various valuation methods and take into account different economic forces when deciding on a price target.